$0.71 EPS Expected for Sonoco Products Co (SON); Biocryst Pharmaceuticals (BCRX) Has 1.38 Sentiment

June 20, 2017 - By Stephen Andrade

BioCryst Pharmaceuticals, Inc. is a biotechnology company. The company has market cap of $465.71 million. The Firm designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. It currently has negative earnings. The Firm focuses on the treatment of rare diseases.

Analysts expect Sonoco Products Co (NYSE:SON) to report $0.71 EPS on July, 20.They anticipate $0.02 EPS change or 2.74% from last quarter’s $0.73 EPS. SON’s profit would be $71.62 million giving it 18.26 P/E if the $0.71 EPS is correct. After having $0.59 EPS previously, Sonoco Products Co’s analysts see 20.34% EPS growth. The stock increased 0.90% or $0.46 during the last trading session, reaching $51.85. About shares traded. Sonoco Products Co (NYSE:SON) has risen 9.55% since June 20, 2016 and is uptrending. It has underperformed by 7.15% the S&P500.

Vhcp Management Llc holds 7.86% of its portfolio in BioCryst Pharmaceuticals, Inc. for 1.16 million shares. Ra Capital Management Llc owns 2.99 million shares or 2.76% of their US portfolio. Moreover, Venbio Select Advisor Llc has 2.09% invested in the company for 1.63 million shares. The New York-based Ghost Tree Capital Llc has invested 1.75% in the stock. Deerfield Management Co, a New York-based fund reported 3.24 million shares.

Since January 1, 0001, it had 0 buys, and 4 sales for $139,783 activity.

The stock increased 3.96% or $0.22 during the last trading session, reaching $5.77. About shares traded. BioCryst Pharmaceuticals, Inc. (BCRX) has risen 75.08% since June 20, 2016 and is uptrending. It has outperformed by 58.38% the S&P500.

Investors sentiment decreased to 0.87 in Q4 2016. Its down 0.02, from 0.89 in 2016Q3. It turned negative, as 23 investors sold Sonoco Products Co shares while 122 reduced holdings. 34 funds opened positions while 92 raised stakes. 70.18 million shares or 2.68% more from 68.35 million shares in 2016Q3 were reported. 19,659 were accumulated by Pub Employees Retirement Association Of Colorado. Panagora Asset has 0.01% invested in Sonoco Products Co (NYSE:SON). Impax Asset Mngmt reported 162,100 shares stake. 18,083 are owned by Utah Retirement Sys. Bancshares Of Mellon accumulated 0.03% or 1.86M shares. Teacher Retirement Sys Of Texas holds 0% or 8,066 shares. Comml Bank Of America Corporation De owns 2.09 million shares. California State Teachers Retirement reported 212,482 shares. Wesbanco Fincl Bank, West Virginia-based fund reported 5,463 shares. Washington Tru Commercial Bank, a Washington-based fund reported 18 shares. Capstone Asset Mngmt holds 9,015 shares. Morgan Stanley reported 0.01% in Sonoco Products Co (NYSE:SON). Blackrock Fund Advsr has 0.07% invested in Sonoco Products Co (NYSE:SON). Archford Capital Strategies Ltd Liability Corp holds 63 shares. Manning And Napier Llc holds 0.01% of its portfolio in Sonoco Products Co (NYSE:SON) for 18,197 shares.

Among 10 analysts covering Sonoco Products Company (NYSE:SON), 1 have Buy rating, 4 Sell and 5 Hold. Therefore 10% are positive. Sonoco Products Company had 18 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Sonoco Products Co (NYSE:SON) earned “Underperform” rating by Bank of America on Monday, October 3. As per Monday, November 23, the company rating was upgraded by Macquarie Research. On Thursday, May 12 the stock rating was initiated by Goldman Sachs with “Neutral”. The firm earned “Sell” rating on Friday, July 22 by Vertical Research. The rating was maintained by Jefferies on Thursday, July 14 with “Hold”. The stock of Sonoco Products Co (NYSE:SON) earned “Hold” rating by Vertical Research on Friday, March 18. Bank of America downgraded Sonoco Products Co (NYSE:SON) on Friday, March 18 to “Neutral” rating. The stock of Sonoco Products Co (NYSE:SON) has “Underweight” rating given on Monday, December 7 by Barclays Capital. The stock of Sonoco Products Co (NYSE:SON) earned “Hold” rating by Deutsche Bank on Monday, November 16. The company was downgraded on Tuesday, August 25 by Zacks.

Since January 4, 2017, it had 0 insider purchases, and 6 selling transactions for $700,190 activity. 9,691 Sonoco Products Co (NYSE:SON) shares with value of $516,977 were sold by Coker R. Howard. 535 Sonoco Products Co (NYSE:SON) shares with value of $28,398 were sold by MAHONEY KEVIN P. $48,620 worth of Sonoco Products Co (NYSE:SON) shares were sold by SCHRUM ROGER P. Another trade for 556 shares valued at $30,302 was sold by Harrell James A. III.

Sonoco Products Company is engaged in manufacturing of industrial and consumer packaging products, and providing packaging services. The company has market cap of $5.23 billion. The Firm operates in four divisions: Consumer Packaging, Paper and Industrial Converted Products, Display and Packaging, and Protective Solutions. It has a 18.76 P/E ratio. The Company’s Consumer Packaging segment’s services and products include round composite cans, aluminum, steel and peelable membrane easy-open closures for composite and metal cans; plastic bottles, cups and trays, and printed flexible packaging and global brand management.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: